The BCI 602 BONEBRIDGE Post-Market Clinical Follow-up Study
Sponsor: MED-EL Elektromedizinische Geräte GesmbH
Listed as NCT04427033, this observational or N/A phase trial focuses on Hearing Loss and Hearing Loss, Bilateral and remains completed. Sponsored by MED-EL Elektromedizinische Geräte GesmbH, it has been updated 9 times since 2019, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
9 versions recorded-
Sep 2025 — Present [monthly]
Completed
-
Sep 2024 — Sep 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Feb 2024 — Jul 2024 [monthly]
Completed
Status: Active Not Recruiting → Completed
-
Mar 2023 — Feb 2024 [monthly]
Active Not Recruiting
Status: Recruiting → Active Not Recruiting
▶ Show 4 earlier versions
-
Feb 2022 — Mar 2023 [monthly]
Recruiting
-
Oct 2021 — Feb 2022 [monthly]
Recruiting
-
Jan 2021 — Oct 2021 [monthly]
Recruiting
-
Jul 2020 — Jan 2021 [monthly]
Recruiting
First recorded
Dec 2019
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- MED-EL Elektromedizinische Geräte GesmbH
For direct contact, visit the study record on ClinicalTrials.gov .